Products

RabAvert^®

(Rabies Vaccine)

Disclaimer

Original Notice of Compliance (NoC)

April 29, 2005

Therapeutic / Pharmacological Classification

Vaccine for:

Pre-exposure vaccination, in both primary series and booster doses against rabies in all age groups.
Post-exposure prophylaxis against rabies in all age groups.

Product Monograph / Prescribing Information / Product Information

Date of Revision: November 23, 2006 (1062-a,11,06)
File name: RabAvert_1062-a_11_06-E.pdf
File size: 493 KB

CONSUMER INFORMATION

Date of Revision: November 23, 2006 (1062-a,11,06)
File name: RabAvert_1062-a_11_06_CI-E.pdf
File size: 423 KB

This file is presented in PDF format. This software is available at no charge through the Adobe Web site. Get Adobe Reader

DISCLAIMER
The contents of this site, including but not limited to Merck Frosst product information and product monographs, are for informational purposes only and are intended solely for residents of Canada, and are not intended, nor should they be used, as a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician, pharmacist or other qualified health care provider with any questions you may have regarding a medical condition.

RabAvert® is a Registered trademark of Novartis Vaccines and Diagnostics GmbH & Co. KG

Printer friendly

Email a friend

This site is for residents of Canada. / This site was updated on May 2, 2008.